HealthOrbit, Inc. - News Headlines

	Curis Publishes CUDC-101 Medicinal Chemistry Data (02.13.10)
	OraSure Technologies Files Additional Data With FDA in Support of PMA Application for OraQuick Rapid HCV Test (01.8.10)
	Oncothyreon's PX-866 PI-3 kinase inhibitor named among Top 10 most promising oncology products for partnering by Windhover (11.18.09)
	Oncolytics Biotech Inc. Announces Journal of Immunology Publication on Reovirus Activation of Dendritic Cells (04.24.08)
	Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K (04.01.08)
	Idenix Announces Data Presentations at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL) (02.026.08)
	Lipid Sciences’ Request To List On Nasdaq Capital Market Approved (12.29.07)
	Oncolytics Biotech Inc. Announces Issuance of 25th U.S. Patent (12.12.07)
	BioXell announces start of Phase IIa trial of Elocalcitol in Male Infertility (11.20.07)
	Emergent BioSolutions Completes Clinical Study in Support of a Post-Exposure Prophylaxis Indication for BioThrax(R) (Anthrax Vaccine Adsorbed) (11.6.07)